Mosaic ImmunoEngineering is a nanotechnology-based immunotherapy company developing therapeutics and vaccines to positively impact the lives of patients and their families.

Free
Message: Once again......

you are entitled to your opinion.  but what has managment done?  ptsc's merger with tpl was for survival.  tpl has produced results.  tpl is in court.  ptsc signed the control to their patent over to tpl and have nothing materially to do with the court case.  ptsc had a glimpse of the cash cow and they wet themselves, paying the entire treasury out in the form of a dividend.  purchasing 10% of stock with revenues was a stated goal but not one that management has followed thru with.  the potential for revenue is huge with the patent and could be considered a cash cow.....so wall street and investors surely read our pr blitzes and can do the dd on the company.....and they bid the stock lower with each signing.  why has the market turned its back on this stock?  it is management or lack of.  s&l run the company and their mo is one of a debt financier.  they have a hand picked bod.  frustrated....you betcha!

t'moto

Share
New Message
Please login to post a reply